← Eichor
Study identifier: NCT05572073 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Otoferlin Gene-mediated Hearing Loss Natural History Study

Condition: Sensorineural Hearing Loss, Bilateral  ·  Sponsor: Akouos, Inc.

PhaseN/A
Planned participants150
Who can joinAll sexes, N/A to 44 Years
Healthy volunteersNo

About this study

This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.

This description comes directly from the study's public registry record.

Talk to the study team

Akouos Clinical Trials  ·  +1 857 410 1816  ·  AkouosClinicalTrials@Lilly.com

Always discuss trial participation with your own doctor first.

Locations (10)

University of IowaIowa City, Iowa, United StatesRecruiting
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio, United StatesRecruiting
Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania, United StatesRecruiting
Vanderbilt University Medical CenterNashville, Tennessee, United StatesRecruiting
Murdoch Children's Research InstituteParkville, Victoria, AustraliaWithdrawn
University Hospital in TübingenTübingen, GermanyRecruiting
Sant Joan de Déu Barcelona HospitalEsplugues de Llobregat, Barcelona, SpainRecruiting
National Taiwan University HospitalTaipei, TaiwanRecruiting
Ankara UniversityAnkara, Turkey, Turkey (Türkiye)Recruiting
University College LondonLondon, United Kingdom, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05572073